FNA (Paragon 28 Corp) Return on Gross Profit

Corporate emblem and logo of Paragon 28, Inc. (FNA)

Paragon 28, Inc. (FNA) revenues depend on insurance reimbursements and the volume of scheduled surgeries. The gross margin distribution visualizes this efficiency, where the value of 67.50 characterizes this level. Optimization is achieved through partnerships with medical centers to implement titanium systems. Business stability is ensured by FDA patent protection and the high switching costs for clinics to move to alternative protocols.

Paragon 28 Inc. (FNA) Gross Profitability: for the period 07/04/2022 - 04/26/2025

Financial and market metric breakdowns for paragon28.com (FNA)

- current quotes and average value forecast:
- business market valuation indicators:
Basic company analysis:FNA (Paragon 28)
Manufactured products of Paragon 28, Inc.

Gross margin measures production efficiency by determining the profit share after deducting direct costs of product creation. Analyzing the trading gross margin allows for tracking profitability trends between quarterly reports by calculating the ratio of the difference between revenue and cost of goods sold to total sales. For Paragon 28, Inc. (FNA), this indicator reflects success in optimizing packaging and instrument reprocessing as part of its ESG strategy.

Key competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Gross Sales Margin|IRADIMED Inc. - Return on Gross Profit|Gross Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Gross Margin|Return on Sales by Gross Profit AxoGen Inc AXGN|SI-BONE (SIBN) - Gross Profitability|Gross Profitability Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Gross Margin|Return on Gross Profit OrthoPediatrics Corp. (KIDS)|Gross Margin TMCI|SRTA - Gross Profit Margin|Gross Profitability Carlsmed Inc CARL|RXST: Gross Return on Sales|CLPT: Return on Gross Profit|stereotaxis.com - Gross Profit Ratio|NeuroStar (STIM) - Gross Profitability|SGHT - Return on Sales by Gross Profit|Gross Profitability Orchestra BioMed|Gross Return on Sales ANIK (Anika Therapeutics)|Gross Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Gross Return on Sales|Gross Margin VANI (Vivani Medical Inc)|XTNT: Gross Return on Sales|NMTC - Gross Profitability|MODD: Gross Profitability|MYO: Gross Margin|envoymedical.com - Gross Profit Rate|Return on Gross Profit VVOS|Gross Profit Margin enVVeno NVNO|Gross Margin SINT|TNON - Gross Profit Margin|Gross Profitability ReWalk Robotics LFWD|AMIX: Gross Return on Sales|IVF - Gross Profitability|Gross Profit Margin Bone Biologics Corp|AXNX: Gross Margin|Return on Gross Profit BIOLASE, Inc.|Return on Gross Profit DYNT|Gross Profit Margin invobioscience.com INVO